Humira costs $550 to $6,922 per month in 2026
Humira costs $6,922 a month at AbbVie's 2026 list price for a standard two pen carton, or about $83,000 a year, and the list price has not fallen even with eight approved biosimilars on the market. The biosimilars are where the savings are. Unbranded adalimumab-adbm runs about $550 a month cash with GoodRx. Yusimry is about $639. Hadlima and Yuflyma are about $1,040. Hyrimoz is about $1,315. Simlandi is about $3,744. With commercial insurance, the Humira Complete card takes patients to $0 to $5 a month. Medicare pays about $927 per 40 mg dose at its rate. Most uninsured patients get Humira or a biosimilar free through myAbbVie Assist. CoveredUSA lists Humira's list price at $6,922 a month in 2026 and biosimilar cash prices at about $550 to $3,744 a month.
What price guides say
We checked 2 price guides and read every number on their pages on October 7, 2026. They do not all measure the same thing, so read each line for what it counts.
| Source | What it found |
|---|---|
| CoveredUSA | CoveredUSA lists Humira's list price at $6,922 a month in 2026 and biosimilar cash prices at about $550 to $3,744 a month. |
| RxDiff | RxDiff lists a 30 day Humira kit at $6,911.73 at Walgreens Specialty and $7,072.57 at Raley's in Reno, Nevada. |
What pushes the price up
| What | Why it matters |
|---|---|
| Brand or biosimilar | The brand is $6,922. Biosimilars are the same medicine for $550 to $3,744. Many plans now require the biosimilar. |
| Which biosimilar | Unbranded adalimumab-adbm and Yusimry are cheapest. Interchangeable ones like Cyltezo can be swapped at the pharmacy without a new prescription. |
| Insurance | Commercial plans cover Humira or a preferred biosimilar after prior authorization. The copay card takes it to $0 to $5. |
| Medicare | Covered under Part D. The 2026 out of pocket cap is $2,100 a year. |
| Dosing | 40 mg every 2 weeks is standard. Weekly dosing for Crohn's or UC doubles the monthly cost. |
What the price includes
The price covers a carton of two prefilled pens or syringes. Nurse training, lab monitoring (TB test, blood counts) and office visits are separate. It does not include tax or extras the provider adds on the day.
Does insurance cover it
Most commercial plans cover Humira or a preferred biosimilar, often after prior approval. Many plans now pick a biosimilar over the brand, so ask which one your plan prefers. Medicare Part D covers it, and CoveredUSA lists a $2,100 yearly out of pocket cap. Medicaid copays are $1 to $4 per prescription, per CoveredUSA. With commercial insurance, a manufacturer copay card can lower your cost a lot. If you have no insurance, the maker runs a patient assistance program. Check your plan list every year, since the preferred drug can change.
How to judge your quote
- Ask if a biosimilar is a choice for you.
- Ask your plan which version it prefers and if it needs prior approval.
- Ask about the copay card and the assistance program.
- A fair cost for most insured patients is a small copay, not the list price.
- Compare the total with the range above: $550 to $6,922 per month for most people in 2026.
Ways to pay less
- Ask your doctor for a biosimilar. Same drug, same results, and $5,000 or more cheaper per month at cash price.
- Enroll in Humira Complete if you have commercial insurance. Most pay $0 to $5 a month for the brand.
- If uninsured, apply to myAbbVie Assist for free drug.
- Check your plan's formulary each year. Many plans switched their preferred adalimumab in 2025 and 2026.
How we got these numbers
The range on this page comes from CoveredUSA and RxDiff. We opened each source page and read every number on it on October 7, 2026. Where the sources disagree, the table above shows each one so you can see the spread. These are planning ranges, not quotes. The written price you are given is the real price.
Common questions
How much does Humira cost per month?
CoveredUSA lists the list price at $6,922 a month. Most people with insurance pay much less.
Is there a cheaper option?
CoveredUSA lists biosimilar cash prices at about $550 to $3,744 a month. Unbranded adalimumab-adbm is about $550.
Does Medicare cover Humira?
CoveredUSA says Medicare Part D has a $2,100 yearly out of pocket cap. Your plan sets the exact copay.
Is a biosimilar worth switching to?
Biosimilars are approved by the FDA and cost less. Ask your doctor if a switch is right for you.